Scientists call for strict control measures to reduce the spread of new COVID-19 variants

A group of scientists is calling on governments to consider the continued use of strict control measures as the only way to reduce the evolution and spread of new COVID-19 variants.

The experts in evolution, virology, infectious disease and genomics - at the University of East Anglia (UEA), Earlham Institute and University of Minnesota - warn that while governments are negotiating a "precarious balance" between saving the economy and preventing COVID-19 fatalities, stronger action now is the best way to mitigate against more serious outcomes from such virulent strains later.

While COVID-19 vaccine deployment is now underway, a threat to vaccine effectiveness comes from other emerging strains, both existing - such as the UK, South Africa and Brazil variants - and those yet to come.

In an editorial for the journal Virulence, Professors Cock van Oosterhout, Neil Hall, Hinh Ly, and its editor-in-chief Prof Kevin Tyler say:

Continuing public health efforts to encourage vaccination as well as continued use of proper personal protective equipment (PPE), such as proper masking and maintaining safe social interactions, is of utmost importance.

Humanity is faced with a new reality. The faster we adapt, the better our long-term prospects. We must stop the evolution and spread of more virulent virus strains now. We, therefore, support public health policies with strict control measures in order to protect our public health system, our individual wellbeing, and our future."

The researchers look back at what has happened and how best to respond now, highlighting that the roll-out of economic stimulus packages and related activities in many countries appears to have fueled the rate of person-to-person transmission.

As a result, they say at the start of winter the population number of the virus continued from a much higher base than would otherwise have been the case, adding: "By not absolutely minimizing the R number when we had the chance, we extended the pathogen transmission chains, providing more opportunity for it to mutate and evolve into more virulent variants."

Additionally, they highlight that an increased virulence - or higher R value - can also result from the virus evolving the ability to infect people for longer. The authors warn that continued virus evolution in animal hosts, such as cats and mink, followed by transmission into susceptible human hosts, poses a significant long-term risk to public health, suggesting that the vaccination of certain domesticated animals might be important to halt further virus evolution and "spillback" events.

"Vaccination against a viral pathogen with such high prevalence globally is without precedent and we, therefore, have found ourselves in unchartered waters. However, what we can be certain about is that, as long as the vaccine stays effective, a higher uptake of the vaccines will: reduce the number of COVID-19-related deaths, stem the spread of the transmissible strain of the virus, and reduce risk of the evolution of other, even more, virulent strains in the future.

"Furthermore, it is not unthinkable that vaccination of some domesticated animal species might also be necessary to curb the spread of the infection."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Mucosal COVID-19 boosters outperform mRNA shots in preventing upper airway infections